Keywords: cipla, arv, price, cut, does, appease, campaigners

Cipla ARV price cut does not appease campaigners

Article | 24 December 2007

Print This

The USA-headquartered AIDS Healthcare Foundation has responded to a "modest price cut" offered in India by generic drug manufacturer Cipla ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in